Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 4
2005 3
2006 4
2007 11
2008 10
2009 6
2010 7
2011 10
2012 13
2013 17
2014 16
2015 7
2016 20
2017 29
2018 23
2019 28
2020 35
2021 46
2022 31
2023 25
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

312 results

Results by year

Filters applied: . Clear all
Page 1
Prognostic outcomes in Japanese patients with metastatic castration-sensitive prostate cancer: Comparative assessments between conventional androgen deprivation therapy (ADT) and ADT with novel androgen receptor signal inhibitor.
Watanabe H, Nakane K, Takahara K, Naiki T, Yasui T, Shiroki R, Koie T, Miyake H. Watanabe H, et al. Among authors: yasui t. Int J Urol. 2024 May 19. doi: 10.1111/iju.15498. Online ahead of print. Int J Urol. 2024. PMID: 38764245
C-Reactive Protein Is a Potential Prognostic Marker in Patient with Advanced or Metastatic Urothelial Carcinoma Treated with Enfortumab Vedotin: A Multi-Center Retrospective Study.
Morikawa T, Naiki T, Sugiyama Y, Naiki-Ito A, Nagai T, Etani T, Iida K, Isobe T, Noda Y, Shimizu N, Aoki M, Gonda M, Banno R, Kubota H, Ando R, Umemoto Y, Kawai N, Yasui T. Morikawa T, et al. Among authors: yasui t. Cancers (Basel). 2024 Apr 28;16(9):1725. doi: 10.3390/cancers16091725. Cancers (Basel). 2024. PMID: 38730675 Free PMC article.
Effectiveness of switch therapy from tyrosine kinase inhibitors to immune checkpoint inhibitors: the need for biomarkers to establish treatment strategies in patients with metastatic renal cell carcinoma.
Tasaki Y, Hamamoto S, Furukawa-Hibi Y, Yasui T. Tasaki Y, et al. Among authors: yasui t. Transl Androl Urol. 2024 Apr 30;13(4):631-634. doi: 10.21037/tau-23-647. Epub 2024 Apr 12. Transl Androl Urol. 2024. PMID: 38721293 Free PMC article. No abstract available.
Real-world data on efficacy/safety and economic impact of nivolumab administered every 2 and 4 weeks among Japanese patients.
Tasaki Y, Ito N, Mimura Y, Sugiyama Y, Ogawa R, Shimura T, Nakamura M, Kawakita D, Hamamoto S, Uemura T, Yokota K, Iida M, Odagiri K, Kimura Y, Hotta Y, Komatsu H, Okuda K, Niimi A, Yasui T, Iwasaki S, Morita A, Kataoka H, Takiguchi S, Furukawa-Hibi Y. Tasaki Y, et al. Among authors: yasui t. Asia Pac J Clin Oncol. 2024 Apr 29. doi: 10.1111/ajco.14073. Online ahead of print. Asia Pac J Clin Oncol. 2024. PMID: 38682421
The impact of crystal phase transition on the hardness and structure of kidney stones.
Michibata U, Maruyama M, Tanaka Y, Yoshimura M, Yoshikawa HY, Takano K, Furukawa Y, Momma K, Tajiri R, Taguchi K, Hamamoto S, Okada A, Kohri K, Yasui T, Usami S, Imanishi M, Mori Y. Michibata U, et al. Among authors: yasui t. Urolithiasis. 2024 Apr 2;52(1):57. doi: 10.1007/s00240-024-01556-5. Urolithiasis. 2024. PMID: 38563829 Free PMC article.
Three-dimensional computed tomography-based resection process map for robot-assisted partial nephrectomy: propensity score matching of a single-center retrospective study.
Okada A, Ohashi K, Hashimoto H, Ota Y, Sugino T, Unno R, Iwatsuki S, Etani T, Taguchi K, Naiki T, Kurokawa S, Hamamoto S, Ando R, Nakane A, Kawai N, Tozawa K, Yasui T. Okada A, et al. Among authors: yasui t. J Surg Oncol. 2024 Mar 12. doi: 10.1002/jso.27615. Online ahead of print. J Surg Oncol. 2024. PMID: 38470556
Late genitourinary toxicity in salvage radiotherapy for prostate cancer after radical prostatectomy: impact of daily fraction doses.
Takano S, Tomita N, Takaoka T, Niwa M, Torii A, Kita N, Okazaki D, Uchiyama K, Nakanishi-Imai M, Ayakawa S, Iida M, Tsuzuki Y, Otsuka S, Manabe Y, Nomura K, Ogawa Y, Miyakawa A, Miyamoto A, Takemoto S, Yasui T, Hiwatashi A. Takano S, et al. Among authors: yasui t. Br J Radiol. 2024 May 7;97(1157):1050-1056. doi: 10.1093/bjr/tqae055. Br J Radiol. 2024. PMID: 38466928
312 results